At Bioqube Ventures, delivering meaningful patient outcomes and strong financial returns go hand in hand. We embed Environmental, Social and Governance (ESG) principles into every stage of our investment process – from opportunity screening to exit.
As an SFDR Article 8 fund, we integrate environmental and social considerations into every investment decision, ensuring our portfolio companies are built for both performance and positive impact.
We invest in therapeutics addressing severe or life-threatening diseases, aiming to improve both the length and quality of life. This work directly supports the UN Sustainable Development Goals (SDGs).
Where Innovation Meets Lives Changed
We developed our proprietary IIMPACT methodology to ensure every company we back have the potential to make a real difference.
Each potential investment is assessed against seven key criteria:
We require a minimum score for investment and update each portfolio company’s score annually to track progress and maintain accountability.
We take a hands-on role to help our companies grow responsibly:
We strive to lead by example – building a diverse, inclusive, and responsible firm, and minimizing our environmental footprint.
For us, responsibility is not a side activity it’s embedded in the way we invest and partner.
